
Sorrento Therapeutics, Inc.
Get Full AccessDescription
- Sorrento Therapeutics is an antibody-centric, clinical stage biopharmaceutical company developing new treatments for cancer, inflammation and autoimmune diseases. Sorrento's lead products are multiple late-stage biosimilar and biobetter antibodies, as well as clinical CAR-T therapies targeting solid tumors.
-
Headquarters:9380 Judicial Drive , San Diego, California, United States
More -
Phone Number: +1 858-526-0947
-
Website: https://www.sorrentotherapeutics.com
-
Employees:220
-
Revenue:$250 - 500M
-
Legal Name:Sorrento Therapeutics, Inc.
-
Sorrento Therapeutics, Inc.'s Social Media
-
Is this data correct?
-
| NAICS Code: 999990 |
Show More
Frequently Asked Questions regarding Sorrento Therapeutics, Inc.
-
Where are Sorrento Therapeutics, Inc.'s Headquarters?
Sorrento Therapeutics, Inc.'s Headquarters are in 9380 Judicial Drive ,San Diego,California,United States
-
What is Sorrento Therapeutics, Inc.'s phone number?
Sorrento Therapeutics, Inc.'s phone number is +1 858-526-0947
-
What is Sorrento Therapeutics, Inc.'s official website?
Sorrento Therapeutics, Inc.'s official website is https://www.sorrentotherapeutics.com
-
What is Sorrento Therapeutics, Inc.'s Revenue?
Sorrento Therapeutics, Inc.'s revenue is $250 - 500M
-
What is Sorrento Therapeutics, Inc.'s NAICS code?
Sorrento Therapeutics, Inc.'s NAICS code is 999990
-
How many employees are working in Sorrento Therapeutics, Inc.
Sorrento Therapeutics, Inc. has 220 employees
-
What is Sorrento Therapeutics, Inc.'s Industry?
Sorrento Therapeutics, Inc. is in the industry of Biotechnology
-
Who is Sorrento Therapeutics, Inc.'s Chief Financial Officer?
Sorrento Therapeutics, Inc.'s Chief Financial Officer is Rich Vincent